Cleared Traditional

K790311 - LDH ISOENZYME REAGENT

K790311 is the FDA 510(k) clearance for LDH ISOENZYME REAGENT by Electrophoresis Corp.. It is a Class 2 Hematology device (product code CFE) cleared through the Traditional 510(k) pathway after a 36-day FDA review.

K790311 · Electrophoresis Corp. · Hematology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Mar 1979
Decision
36d
Days
Class 2
Risk

K790311 is an FDA 510(k) clearance for the LDH ISOENZYME REAGENT. Classified as Electrophoretic, Lactate Dehydrogenase Isoenzymes (product code CFE), Class II - Special Controls.

Submitted by Electrophoresis Corp. (Mchenry, US). The FDA issued a Cleared decision on March 21, 1979 after a review of 36 days - a notably fast clearance cycle.

This device falls under the Hematology FDA review panel, regulated under 21 CFR 862.1445 - the FDA hematology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Electrophoresis Corp. devices

Submission Details

510(k) Number K790311 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 13, 1979
Decision Date March 21, 1979
Days to Decision 36 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
77d faster than avg
Panel avg: 113d · This submission: 36d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code CFE Electrophoretic, Lactate Dehydrogenase Isoenzymes
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 862.1445
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Hematology devices follow this clearance model.

Regulatory Peers - CFE Electrophoretic, Lactate Dehydrogenase Isoenzymes

All 23
Devices cleared under the same product code (CFE) and FDA review panel - the closest regulatory comparables to K790311.
TRANSPHOR TM LD LACTATE DEHYDROGENASE
K800568 · Corning Medical & Scientific · Apr 1980
ROCHE IMMUNOCHEMICAL LD ISOENZY REAGENTS
K791373 · Hoffmann-La Roche, Inc. · Oct 1979
LDH CLINI GEL KIT
K791827 · Clinical Sciences, Inc. · Oct 1979
LACTATE DEHYDROGENASE COLORIMETRIC SUB.
K780080 · Corning Medical & Scientific · Feb 1978